Patent Category: Therapies

Composition containing peptide IM, the set and application for stimulation of regeneration of a complex tissue or treatment of wounds

01.09.2020

The subject of the patent application is a pharmaceutical composition that contains an IM peptide at a concentration of 0.1 - 50 µg/ml and/or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable vehicle and/or diluent. Also the subject of the patent application is a set for stimulating regeneration of complex tissue or wound healing that contains the above composition. Further, the subject of the patent application also relates to the use of an IM peptide ...

Chemical compounds with anti-damage and/or neuroprotective effects

01.09.2020

The present invention relates to chemical compounds with injury-reducing and/or neuroprotective properties. The compounds are preferably selected from the group: RGD1; RGD2; RGD3; RGD4; AcRGDl; ...

Use of epigenetic inhibitor 1-(β-D-ribofuranosyol)-2(1H)-pyrimidinone (zebularine) for promoting wound healing, complex tissue and organ regeneration

01.09.2020

In one aspect, the present invention provides a composition comprising zebularine, a nucleotide inhibitor of DNA methyltransferase, optionally in combination with retinoic acid, and said ...

New peptide derivatives of platelet-derived growth factor (PDGF), method for obtaining, pharmaceutical composition and application

01.09.2020

The present invention relates to novel peptide derivatives of platelet derived growth factor (PDGF) and a method for their preparation. In addition, the invention relates to a pharmaceutical ...

Prion protein-dendrimer conjugates for use in the treatment of Alzheimer disease

01.09.2020

Oligomers of Aβ peptide are strong neurotoxins and their presence correlates with the progression of pathological changes in patients with Alzheimer's disease (AD), especially the so-called ...